Pharvaris (PHVS) Stock Chart & Stock Price History $18.30 +0.28 (+1.53%) Closing price 03:59 PM EasternExtended Trading$18.23 -0.08 (-0.44%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Pharvaris Stock Price Performance The Pharvaris (PHVS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 14.41%, with a year-to-date return of -4.51%. In the past month, the stock has increased 7.74%, reflecting recent market activity. As of the latest close, Pharvaris traded at $18.03 with a market cap of $942.79 million and volume of 64,706 shares. Receive PHVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pharvaris and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+14.05%1 Month Performance+7.74%3 Month Performance+22.85%Year-To-Date Performance-4.51%1 Year Performance+14.41% PHVS Stock Chart for Tuesday, June, 10, 2025 PHVS Chart by TradingView Pharvaris Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/09/2025$16.78$18.03+7.45%$18.34$16.3664,706 shs$942.79 million06/06/2025$16.05$16.78+4.55%$17.19$15.9982,545 shs$877.43 million06/05/2025$16.62$16.05-3.43%$16.88$15.9181,019 shs$839.25 million06/04/2025$17.28$16.62-3.82%$17.30$16.5767,922 shs$869.06 million06/03/2025$16.49$17.28+4.79%$18.00$16.42156,686 shs$903.57 million06/02/2025$16.53$16.49-0.24%$16.88$16.20110,708 shs$862.26 million05/30/2025$16.72$16.53-1.14%$16.99$16.26189,848 shs$864.35 million05/29/2025$15.46$16.72+8.15%$16.90$15.51113,365 shs$874.29 million05/28/2025$15.84$15.46-2.40%$15.85$15.4611,424 shs$808.40 million05/27/2025$15.99$15.84-0.94%$16.50$15.8373,135 shs$828.27 million Get the Latest News and Ratings for PHVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharvaris and its competitors with MarketBeat's FREE daily newsletter. 05/26/2025$15.99$15.99$16.14$15.8416,327 shs$836.12 million05/23/2025$16.39$15.99-2.44%$16.14$15.8416,327 shs$836.12 million05/22/2025$16.40$16.39-0.06%$16.56$15.9867,224 shs$857.03 million05/21/2025$17.25$16.40-4.93%$17.00$16.0727,457 shs$857.56 million05/20/2025$16.69$17.25+3.36%$17.25$16.2744,791 shs$902.00 million05/19/2025$16.56$16.69+0.79%$16.98$15.7239,946 shs$872.72 million05/16/2025$15.91$16.56+4.09%$16.61$15.5040,381 shs$865.92 million05/15/2025$16.07$15.91-1.00%$17.10$15.3422,685 shs$831.93 million05/14/2025$16.11$16.07-0.25%$17.08$14.59123,891 shs$840.30 million05/13/2025$16.81$16.11-4.16%$17.05$15.7340,500 shs$842.39 million05/12/2025$16.99$16.81-1.06%$17.26$16.5716,244 shs$879.00 million05/09/2025$17.04$16.99-0.29%$17.27$16.5615,489 shs$888.41 million Related Companies Zai Lab Stock Price Chart Ultragenyx Pharmaceutical Stock Price Chart Arcellx Stock Price Chart Alvotech Stock Price Chart Protagonist Therapeutics Stock Price Chart Catalyst Pharmaceuticals Stock Price Chart Crinetics Pharmaceuticals Stock Price Chart Metsera Stock Price Chart Viking Therapeutics Stock Price Chart MorphoSys Stock Price Chart Receive PHVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pharvaris and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PHVS) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsA major regulatory shift is scheduled to take effect this July — and it could have serious implications for yo...Monetary Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored“Biggest Social Security Change Ever”The Financial Times called this new Trump initiative "a big pot of money for the American people." And The Mot...InvestorPlace | SponsoredTrump’s Secret WeaponThe Trump-Elon War Could Trigger an Economic Collapse - Here's Your Only Safe Exit This isn't just a war of...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharvaris Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharvaris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
